Table 2.

Cytogenetic and Molecular Response to Dasatinib Over Time

Time on Therapy (months)	Cytogenetic			Molecular
	No. of Patients at Risk	Major Response (%)	Complete Response (%)	No. of Patients at Risk	Major Response (%)	Complete Response (%)
3	50	96	82	50	24	0
6	49	98	94	49	63	0
12	42	98	98	42	71	7
18	35	91	89	34	79	6
24	31	87	84	31	87	6
30	23	83	83	21	81	0